There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can help researchers identify new antimicrobials.

Most infection prevention guidelines center on the hospital environment rather than the patient. But the source of antibiotic-resistant microbes is often from the patient’s own body.

Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

New research finds a key clue that sheds light on the spread and evolution of antibiotic resistance.

Researchers trying to harness electricity from bacteria realized they may be onto solving another issue: antibiotic resistance.

The Nobel Prize-winning Luria−Delbrück experiment showed that random mutations in bacteria can allow them to develop resistance by chance.

Researchers have found a virus kills "sleeping" bacteria. The discovery could help fight germs that can't be treated with antibiotics alone.

These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.

A combination of antibiotics is more effective in treating Lyme disease than the commonly prescribed course of a single antibiotic alone.

Researchers have found a way to deploy a molecular "warhead" that can annihilate the bacterium that causes Lyme disease.